ID SRTD3_HUMAN Reviewed; 196 AA. AC Q9UJW9; B3KQB3; Q96CQ2; DT 01-FEB-2005, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-2005, sequence version 2. DT 24-JAN-2024, entry version 150. DE RecName: Full=SERTA domain-containing protein 3; DE AltName: Full=Replication protein-binding trans-activator; DE Short=RPA-binding trans-activator; GN Name=SERTAD3; Synonyms=RBT1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION RP WITH RPA2. RX PubMed=10982866; DOI=10.1093/nar/28.18.3478; RA Cho J.M., Song D.J., Bergeron J., Benlimame N., Wold M.S., RA Alaoui-Jamali M.A.; RT "RBT1, a novel transcriptional co-activator, binds the second subunit of RT replication protein A."; RL Nucleic Acids Res. 28:3478-3485(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Embryo; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Ovary, and Uterus; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP FUNCTION, INDUCTION BY TYPE I INTERFERON, SUBCELLULAR LOCATION, AND RP INTERACTION WITH INFLUENZA VIRUS PROTEINS PA; PB1 AND PB2 (MICROBIAL RP INFECTION). RX PubMed=33147462; DOI=10.1016/j.celrep.2020.108342; RA Sun N., Li C., Li X.F., Deng Y.Q., Jiang T., Zhang N.N., Zu S., Zhang R.R., RA Li L., Chen X., Liu P., Gold S., Lu N., Du P., Wang J., Qin C.F., Cheng G.; RT "Type-IInterferon-Inducible SERTAD3 Inhibits Influenza A Virus Replication RT by Blocking the Assembly of Viral RNA Polymerase Complex."; RL Cell Rep. 33:108342-108342(2020). RN [6] RP FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH ZIKA VIRUS CAPSID PROTEIN RP (MICROBIAL INFECTION), AND INDUCTION BY ZIKA VIRUS INFECTION. RX PubMed=36594413; DOI=10.1002/jmv.28451; RA Sun N., Zhang R.R., Song G.Y., Cai Q., Aliyari S.R., Nielsen-Saines K., RA Jung J.U., Yang H., Cheng G., Qin C.F.; RT "SERTAD3 induces proteasomal degradation of ZIKV capsid protein and RT represents a therapeutic target."; RL J. Med. Virol. 0:0-0(2023). CC -!- FUNCTION: Antiviral interferon-stimulated protein that plays a role in CC innate immunity and in the suppression of viruses through different CC mechanisms (PubMed:33147462, PubMed:36594413). Plays a role in the late CC phase response of TLR-induced immune effector expression (By CC similarity). During influenza infection, interacts with PB2, PB1, and CC PA to disrupt the formation of the viral RdRp complex CC (PubMed:33147462). Inhibits zika virus by interacting with the capsid CC protein in the nucleolus and reducing its abundance through proteasomal CC degradation (PubMed:36594413). Strong transcriptional coactivator CC (PubMed:10982866). {ECO:0000250|UniProtKB:Q9ERC3, CC ECO:0000269|PubMed:10982866, ECO:0000269|PubMed:33147462, CC ECO:0000269|PubMed:36594413}. CC -!- SUBUNIT: Interacts with RPA2. {ECO:0000269|PubMed:10982866}. CC -!- SUBUNIT: (Microbial infection) Interacts with influenza virus PA, PB1 CC and PB2,leading to inhibition of RdRp complex assembly. CC {ECO:0000269|PubMed:33147462}. CC -!- SUBUNIT: (Microbial infection) Interacts with zika virus capsid CC protein. {ECO:0000269|PubMed:36594413}. CC -!- INTERACTION: CC Q9UJW9; X5D778: ANKRD11; NbExp=3; IntAct=EBI-748621, EBI-17183751; CC Q9UJW9; Q9BXY8: BEX2; NbExp=3; IntAct=EBI-748621, EBI-745073; CC Q9UJW9; Q13515: BFSP2; NbExp=3; IntAct=EBI-748621, EBI-10229433; CC Q9UJW9; Q8TAB5: C1orf216; NbExp=3; IntAct=EBI-748621, EBI-747505; CC Q9UJW9; P24863: CCNC; NbExp=3; IntAct=EBI-748621, EBI-395261; CC Q9UJW9; Q6IPU0: CENPP; NbExp=3; IntAct=EBI-748621, EBI-10250303; CC Q9UJW9; Q96LK0: CEP19; NbExp=3; IntAct=EBI-748621, EBI-741885; CC Q9UJW9; Q9UI47-2: CTNNA3; NbExp=3; IntAct=EBI-748621, EBI-11962928; CC Q9UJW9; Q9UBT7: CTNNAL1; NbExp=3; IntAct=EBI-748621, EBI-514206; CC Q9UJW9; Q9UER7: DAXX; NbExp=3; IntAct=EBI-748621, EBI-77321; CC Q9UJW9; Q6W0C5: DPPA3; NbExp=3; IntAct=EBI-748621, EBI-12082590; CC Q9UJW9; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-748621, EBI-744099; CC Q9UJW9; Q6NZ36-4: FAAP20; NbExp=3; IntAct=EBI-748621, EBI-12013806; CC Q9UJW9; Q9H4M3: FBXO44; NbExp=3; IntAct=EBI-748621, EBI-2322644; CC Q9UJW9; O94868-3: FCHSD2; NbExp=3; IntAct=EBI-748621, EBI-11958845; CC Q9UJW9; Q969Y2: GTPBP3; NbExp=3; IntAct=EBI-748621, EBI-740290; CC Q9UJW9; Q9Y5R4: HEMK1; NbExp=3; IntAct=EBI-748621, EBI-10329202; CC Q9UJW9; O14964: HGS; NbExp=3; IntAct=EBI-748621, EBI-740220; CC Q9UJW9; Q14005-2: IL16; NbExp=3; IntAct=EBI-748621, EBI-17178971; CC Q9UJW9; Q9NV31: IMP3; NbExp=3; IntAct=EBI-748621, EBI-747481; CC Q9UJW9; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-748621, EBI-2556193; CC Q9UJW9; Q9P2K6: KLHL42; NbExp=3; IntAct=EBI-748621, EBI-739890; CC Q9UJW9; P52292: KPNA2; NbExp=4; IntAct=EBI-748621, EBI-349938; CC Q9UJW9; O95983-2: MBD3; NbExp=3; IntAct=EBI-748621, EBI-11978579; CC Q9UJW9; Q71SY5: MED25; NbExp=3; IntAct=EBI-748621, EBI-394558; CC Q9UJW9; A6NI15: MSGN1; NbExp=3; IntAct=EBI-748621, EBI-11991020; CC Q9UJW9; P16860: NPPB; NbExp=3; IntAct=EBI-748621, EBI-747044; CC Q9UJW9; Q7Z3B4: NUP54; NbExp=3; IntAct=EBI-748621, EBI-741048; CC Q9UJW9; Q7Z4N8: P4HA3; NbExp=3; IntAct=EBI-748621, EBI-10181968; CC Q9UJW9; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-748621, EBI-79165; CC Q9UJW9; Q16512: PKN1; NbExp=3; IntAct=EBI-748621, EBI-602382; CC Q9UJW9; P54646: PRKAA2; NbExp=3; IntAct=EBI-748621, EBI-1383852; CC Q9UJW9; P15927: RPA2; NbExp=5; IntAct=EBI-748621, EBI-621404; CC Q9UJW9; Q14D33: RTP5; NbExp=3; IntAct=EBI-748621, EBI-10217913; CC Q9UJW9; Q96GM5: SMARCD1; NbExp=3; IntAct=EBI-748621, EBI-358489; CC Q9UJW9; P14678-2: SNRPB; NbExp=4; IntAct=EBI-748621, EBI-372475; CC Q9UJW9; Q96JI7: SPG11; NbExp=3; IntAct=EBI-748621, EBI-2822128; CC Q9UJW9; Q6ZRS2-3: SRCAP; NbExp=3; IntAct=EBI-748621, EBI-12029182; CC Q9UJW9; P51687: SUOX; NbExp=5; IntAct=EBI-748621, EBI-3921347; CC Q9UJW9; Q5VWN6: TASOR2; NbExp=3; IntAct=EBI-748621, EBI-745958; CC Q9UJW9; Q08117-2: TLE5; NbExp=3; IntAct=EBI-748621, EBI-11741437; CC Q9UJW9; O14787-2: TNPO2; NbExp=3; IntAct=EBI-748621, EBI-12076664; CC Q9UJW9; Q8N7U7-2: TPRX1; NbExp=3; IntAct=EBI-748621, EBI-14115717; CC Q9UJW9; O75865-2: TRAPPC6A; NbExp=3; IntAct=EBI-748621, EBI-8451480; CC Q9UJW9; Q9BSJ2: TUBGCP2; NbExp=3; IntAct=EBI-748621, EBI-357881; CC Q9UJW9; P10599: TXN; NbExp=3; IntAct=EBI-748621, EBI-594644; CC Q9UJW9; Q9BZL1: UBL5; NbExp=4; IntAct=EBI-748621, EBI-607755; CC Q9UJW9; Q8N6Y0: USHBP1; NbExp=7; IntAct=EBI-748621, EBI-739895; CC Q9UJW9; Q96DA0: ZG16B; NbExp=5; IntAct=EBI-748621, EBI-953824; CC Q9UJW9; Q8N5A5-2: ZGPAT; NbExp=3; IntAct=EBI-748621, EBI-10183064; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10982866}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF192529; AAF05761.1; -; mRNA. DR EMBL; AK074604; BAG51975.1; -; mRNA. DR EMBL; CH471126; EAW56966.1; -; Genomic_DNA. DR EMBL; BC014061; AAH14061.1; -; mRNA. DR EMBL; BC050643; AAH50643.1; -; mRNA. DR CCDS; CCDS12558.1; -. DR RefSeq; NP_037500.2; NM_013368.3. DR RefSeq; NP_976219.1; NM_203344.2. DR RefSeq; XP_005258889.1; XM_005258832.3. DR RefSeq; XP_006723242.1; XM_006723179.3. DR AlphaFoldDB; Q9UJW9; -. DR BioGRID; 118983; 47. DR IntAct; Q9UJW9; 68. DR STRING; 9606.ENSP00000375882; -. DR iPTMnet; Q9UJW9; -. DR PhosphoSitePlus; Q9UJW9; -. DR BioMuta; SERTAD3; -. DR DMDM; 60415943; -. DR EPD; Q9UJW9; -. DR PaxDb; 9606-ENSP00000325414; -. DR PeptideAtlas; Q9UJW9; -. DR Antibodypedia; 55379; 60 antibodies from 16 providers. DR DNASU; 29946; -. DR Ensembl; ENST00000322354.4; ENSP00000325414.2; ENSG00000167565.13. DR Ensembl; ENST00000392028.8; ENSP00000375882.3; ENSG00000167565.13. DR GeneID; 29946; -. DR KEGG; hsa:29946; -. DR MANE-Select; ENST00000322354.4; ENSP00000325414.2; NM_203344.3; NP_976219.1. DR UCSC; uc002onu.5; human. DR AGR; HGNC:17931; -. DR CTD; 29946; -. DR DisGeNET; 29946; -. DR GeneCards; SERTAD3; -. DR HGNC; HGNC:17931; SERTAD3. DR HPA; ENSG00000167565; Low tissue specificity. DR MIM; 612125; gene. DR neXtProt; NX_Q9UJW9; -. DR OpenTargets; ENSG00000167565; -. DR PharmGKB; PA134941720; -. DR VEuPathDB; HostDB:ENSG00000167565; -. DR eggNOG; ENOG502RY30; Eukaryota. DR GeneTree; ENSGT00940000154733; -. DR HOGENOM; CLU_097197_0_0_1; -. DR InParanoid; Q9UJW9; -. DR OMA; PGPQNEV; -. DR OrthoDB; 4603198at2759; -. DR PhylomeDB; Q9UJW9; -. DR TreeFam; TF101069; -. DR PathwayCommons; Q9UJW9; -. DR SignaLink; Q9UJW9; -. DR BioGRID-ORCS; 29946; 16 hits in 1164 CRISPR screens. DR GenomeRNAi; 29946; -. DR Pharos; Q9UJW9; Tbio. DR PRO; PR:Q9UJW9; -. DR Proteomes; UP000005640; Chromosome 19. DR RNAct; Q9UJW9; Protein. DR Bgee; ENSG00000167565; Expressed in oocyte and 154 other cell types or tissues. DR ExpressionAtlas; Q9UJW9; baseline and differential. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0030308; P:negative regulation of cell growth; IDA:MGI. DR GO; GO:0045893; P:positive regulation of DNA-templated transcription; IBA:GO_Central. DR GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:UniProtKB. DR InterPro; IPR009263; SERTA_dom. DR InterPro; IPR039585; SERTAD3. DR PANTHER; PTHR15530; SERTA DOMAIN-CONTAINING PROTEIN 3; 1. DR PANTHER; PTHR15530:SF0; SERTA DOMAIN-CONTAINING PROTEIN 3; 1. DR Pfam; PF06031; SERTA; 1. DR PROSITE; PS51053; SERTA; 1. DR Genevisible; Q9UJW9; HS. PE 1: Evidence at protein level; KW Activator; Nucleus; Reference proteome; Transcription; KW Transcription regulation. FT CHAIN 1..196 FT /note="SERTA domain-containing protein 3" FT /id="PRO_0000191615" FT DOMAIN 26..73 FT /note="SERTA" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00396" FT REGION 1..21 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 104..125 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 107..121 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT CONFLICT 2 FT /note="V -> E (in Ref. 1; AAF05761)" FT /evidence="ECO:0000305" SQ SEQUENCE 196 AA; 21769 MW; 9C54AFA126F17AF1 CRC64; MVGGLKRKHS DLEEEEERWE WSPAGLQSYQ QALLRISLDK VQRSLGPRAP SLRRHVLIHN TLQQLQAALR LAPAPALPPE PLFLGEEDFS LSATIGSILR ELDTSMDGTE PPQNPVTPLG LQNEVPPQPD PVFLEALSSR YLGDSGLDDF FLDIDTSAVE KEPARAPPEP PHNLFCAPGS WEWNELDHIM EIILGS //